Oraya Therapeutics
Newark
About Oraya Therapeutics
Oraya Therapeutics is currently testing its first application of the IRay system. Oraya Therapeutics develops noninvasive robotically controlled treatments for inflammatory and neovascular diseases of the eye.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $97.3M
- Funding stage: Late Stage Venture
- Last round: Grant (Aug 2014)
- Website: orayainc.com
- Phone: +1 (510)456-3700
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/oraya-therapeutics-2851092 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.